2024
An Interventional Radiologist's Guide to Lung Cancer
Fish A, Madoff D. An Interventional Radiologist's Guide to Lung Cancer. Seminars In Interventional Radiology 2024, 41: 121-128. PMID: 38993601, PMCID: PMC11236454, DOI: 10.1055/s-0044-1786725.Peer-Reviewed Original ResearchLung cancer patientsLung cancerTissue diagnosisInterventional radiologistsCancer patientsField of interventional oncologyTreating lung cancer patientsTreatment of lung cancerEarly-stage diseaseAdvanced medical therapiesLung cancer complicationsBiopsy complicationsRadiation therapyPercutaneous ablationSurgical therapyMedical therapyInterventional oncologyEndovascular therapyInvasive treatmentCancer complicationsCancer deathTherapyGold standardCancerTreatment pathways
2022
Oncopharmacology in Interventional Radiology
Raja J, Madoff D. Oncopharmacology in Interventional Radiology. Seminars In Interventional Radiology 2022, 39: 411-415. PMID: 36406031, PMCID: PMC9671678, DOI: 10.1055/s-0042-1758076.Peer-Reviewed Original Research
2020
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
Motzer RJ, Jonasch E, Boyle S, Carlo MI, Manley B, Agarwal N, Alva A, Beckermann K, Choueiri TK, Costello BA, Derweesh IH, Desai A, George S, Gore JL, Haas N, Hancock SL, Kyriakopoulos C, Lam ET, Lau C, Lewis B, Madoff DC, McCreery B, Michaelson MD, Mortazavi A, Nandagopal L, Pierorazio PM, Plimack ER, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Somer B, Sosman J, Dwyer MA, Motter AD. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021. Journal Of The National Comprehensive Cancer Network 2020, 18: 1160-1170. PMID: 32886895, PMCID: PMC10191771, DOI: 10.6004/jnccn.2020.0043.Peer-Reviewed Original ResearchConceptsRenal cell carcinomaKidney cancerStage IV renal cell carcinomaHereditary RCC syndromesNCCN Guidelines InsightsSystemic therapy recommendationsTreatment of patientsNCCN guidelinesRCC syndromesCell carcinomaMultidisciplinary recommendationsTreatment optionsDiagnostic workupTherapy recommendationsGenetic testingPatientsSyndromeCancerRecent updatesGuidelinesCarcinomaWorkupStagingRecommendationsEmbolotherapy for Hepatic Oncology: Current Perspectives and Future Directions
Bajwa R, Madoff DC, Kishore SA. Embolotherapy for Hepatic Oncology: Current Perspectives and Future Directions. Digestive Disease Interventions 2020, 04: 134-147. PMID: 32832829, PMCID: PMC7437993, DOI: 10.1055/s-0040-1712146.Peer-Reviewed Original ResearchSecondary liver tumorsLiver tumorsTransarterial liver-directed therapiesLocoregional treatment strategiesLiver-directed therapiesSecondary liver cancerSelective internal radiotherapyHepatic oncologySystemic therapyBland embolizationTreatment strategiesLiver cancerInternal radiotherapyMajor causeEmbolotherapyTherapyTumorsCurrent perspectivesSupportive evidenceModalitiesChemoembolizationEmbolizationRadiotherapyCancerMortality
2018
Percutaneous Cryoablation for the Management of Chronic Pain Secondary to Locally Recurrent Rectal Cancer with Bowel and Nerve Root Involvement
Cornman-Homonoff J, Formenti SC, Chachoua A, Madoff DC. Percutaneous Cryoablation for the Management of Chronic Pain Secondary to Locally Recurrent Rectal Cancer with Bowel and Nerve Root Involvement. Journal Of Vascular And Interventional Radiology 2018, 29: 1296-1298. PMID: 30146202, DOI: 10.1016/j.jvir.2018.02.022.Peer-Reviewed Case Reports and Technical Notes
2017
Radioembolization in Colorectal Metastases: A Review
Abdelsalam M, Mahvash A, Madoff D, Odisio B, Kuban J, Avritscher R, Murthy R. Radioembolization in Colorectal Metastases: A Review. Digestive Disease Interventions 2017, 01: 208-217. DOI: 10.1055/s-0037-1607965.Peer-Reviewed Original Research
2007
Hepatic Yttrium-90 Radioembolotherapy in Metastatic Colorectal Cancer Treated with Cetuximab or Bevacizumab
Murthy R, Eng C, Krishnan S, Madoff DC, Habbu A, Canet S, Hicks ME. Hepatic Yttrium-90 Radioembolotherapy in Metastatic Colorectal Cancer Treated with Cetuximab or Bevacizumab. Journal Of Vascular And Interventional Radiology 2007, 18: 1588-1591. PMID: 18057297, DOI: 10.1016/j.jvir.2007.08.015.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBevacizumabCetuximabColorectal NeoplasmsCombined Modality TherapyFemaleHumansLiver NeoplasmsMaleMicrospheresMiddle AgedRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonTomography, X-Ray ComputedTreatment OutcomeYttrium RadioisotopesConceptsColorectal cancerTreatment experienceAdvanced unresectable colorectal cancerUnresectable colorectal cancerMetastatic colorectal cancerCohort of patientsYttrium-90 microspheresSystemic therapyBiologic agentsDrug AdministrationHepatic neoplasiaCetuximabPatientsCancerBevacizumabChemotherapyNeoplasiaTherapyCohortPhysiciansAdministration